uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Effects on mortality of abciximab in ST-elevation myocardial infarction treated with percutaneous coronary intervention including stent implantation
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
2006 (English)In: Journal of Internal Medicine, ISSN 0954-6820, E-ISSN 1365-2796, Vol. 260, no 4, 363-368 p.Article in journal (Refereed) Published
Abstract [en]

Objectives. To investigate the effects of abciximab on mortality in ST-elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI) including stent implantation. Design. Meta-analysis of three selected randomized studies and analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Subjects. Pooled data from randomized studies containing in total 1736 patients undergoing PCI with stent implantation because of STEMI with duration between symptom and treatment < 12 h, and 7436 patients from SCAAR treated with PCI because of STEMI (52% treated with abciximab) in Sweden 2000-2004. Results. Analyses of pooled data showed that abciximab was associated with a decreased risk of reinfarction [odds ratio (OR) 0.38] and urgent target vessel revascularization (OR 0.38) at 30 days. No effect was seen on mortality at 30 days or 6 months. Multivariate analysis of data from SCAAR showed that abciximab reduced the risk of death during 14 months of follow-up (hazard ratio 0.82). Conclusions. The results are encouraging and support the ACC/AHA and ESC recommendation to use abciximab in treatment of STEMI with PCI including stent implantation. Considering that the pooled results from previous trials showed no effect of abciximab on mortality and the registry part of the present study was observational, the results encourage carrying out new randomized studies of abciximab in STEMI treated with PCI, including stent implantation, with sufficient size and length of follow-up.

Place, publisher, year, edition, pages
2006. Vol. 260, no 4, 363-368 p.
Keyword [en]
abciximab, PCI, STEMI
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-155120DOI: 10.1111/j.1365-2796.2006.01696.xISI: 000240406900007PubMedID: 16961673OAI: oai:DiVA.org:uu-155120DiVA: diva2:423926
Available from: 2011-06-16 Created: 2011-06-16 Last updated: 2012-07-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lagerqvist, Bo
By organisation
Department of Medical Sciences
In the same journal
Journal of Internal Medicine
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 177 hits
ReferencesLink to record
Permanent link

Direct link